Pharmaceutical manufacturers and payers have developed a number of agreements under which reimbursement is contingent on specific outcomes over the last few years
Emory Healthcare’s Specialty Pharmacy Service was established to meet the needs of patients and providers, in the setting of an evolving healthcare landscape
I failed to discern the implication of the actions proposed by the HHS-FDA Safe Importation Action Plan and the magnitude of its impact to rebates.
Employer Perspectives Specialty Drug Step-Therapy Program Evaluation American Health and Drug Benefits, September 2016 Vol 9, No 6 – Industry Trends Matthew Harman, PharmD, MPH, Director, Clinical Pharmacy Strategies Employers Health, Columbus, OH F. Randy Vogenberg, PhD, RPh, Strategic Advisor and Co–Project Leader, Midwest Business Group on Health National Employer Biologics & Specialty Drug Initiative […]
Closing Gaps in Health Plan Performance with Stakeholder Collaboration Published in American Health & Drug Benefits, October 2015, Vol 8, No 7, Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment F. Randy Vogenberg, PhD, RPh, Partner, Access Market Intelligence Employers/Health Plans: For most commercial health plans and employer-sponsored health plans, immunology represents a […]